BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 22527345)

  • 21. Evaluation of lansoprazole as a probe for assessing cytochrome P450 2C19 activity and genotype-phenotype correlation in childhood.
    Gumus E; Karaca O; Babaoglu MO; Baysoy G; Balamtekin N; Demir H; Uslu N; Bozkurt A; Yuce A; Yasar U
    Eur J Clin Pharmacol; 2012 May; 68(5):629-36. PubMed ID: 22076562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
    Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
    Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluating the relationship between carisoprodol concentrations and meprobamate formation and inter-subject and intra-subject variability in urinary excretion data of pain patients.
    Tse SA; Atayee RS; Best BM; Pesce AJ
    J Anal Toxicol; 2012 May; 36(4):221-31. PubMed ID: 22511696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stimulant and relaxant drugs combined with stimulant and relaxant information: a study of active placebo.
    Flaten MA; Simonsen T; Zahlsen K; Aamo T; Sager G; Olsen H
    Psychopharmacology (Berl); 2004 Nov; 176(3-4):426-34. PubMed ID: 15549277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carisoprodol concentrations from different anatomical sites: three overdose cases.
    Backer RC; Zumwalt R; McFeeley P; Veasey S; Wohlenberg N
    J Anal Toxicol; 1990; 14(5):332-4. PubMed ID: 2263072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Quantitative determination of meprobamate and carisoprodol by gas chromatography in different cases of poisoning].
    Maes R; Bouche R; Laruelle L
    Eur J Toxicol; 1970; 3(2):140-3. PubMed ID: 5520468
    [No Abstract]   [Full Text] [Related]  

  • 27. CYP2C19 genotypes in a population of healthy volunteers and in children with hematological malignancies in Gaza Strip.
    Sameer AE; Amany GM; Abdela AA; Fadel SA
    Can J Clin Pharmacol; 2009; 16(1):e156-62. PubMed ID: 19193970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic Polymorphism of Drug-Metabolizing Enzymes CYP2C9 and CYP2C19 in Moroccan Population.
    Afilal D; Basselam MA; Brakez Z; Chouham S; Brehm A; Izaabel EH
    Genet Test Mol Biomarkers; 2017 May; 21(5):298-304. PubMed ID: 28282224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The polymorphism of cytochrome P(450) 2C19 gene in patients with invasive fungal infections.].
    Wu JQ; Zhu LP; Ou XT; Xu B; Zhang QQ; Weng XH
    Zhonghua Nei Ke Za Zhi; 2010 Feb; 49(2):138-41. PubMed ID: 20356512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carriage of cytochrome 2C19 polymorphism is associated with risk of high post-treatment platelet reactivity on high maintenance-dose clopidogrel of 150 mg/day: results of the ACCEL-DOUBLE (Accelerated Platelet Inhibition by a Double Dose of Clopidogrel According to Gene Polymorphism) study.
    Jeong YH; Kim IS; Park Y; Kang MK; Koh JS; Hwang SJ; Kwak CH; Hwang JY
    JACC Cardiovasc Interv; 2010 Jul; 3(7):731-41. PubMed ID: 20650435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population.
    Zand N; Tajik N; Moghaddam AS; Milanian I
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):102-5. PubMed ID: 17201743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carisoprodol (Soma): a new and cautious perspective on an old agent.
    Littrell RA; Hayes LR; Stillner V
    South Med J; 1993 Jul; 86(7):753-6. PubMed ID: 8322081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphisms of CYP2C19 influences the response to clopidogrel in ischemic heart disease patients in the South Indian Tamilian population.
    Subraja K; Dkhar SA; Priyadharsini R; Ravindra BK; Shewade DG; Satheesh S; Sridhar MG; Narayan SK; Adithan C
    Eur J Clin Pharmacol; 2013 Mar; 69(3):415-22. PubMed ID: 22955794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic polymorphism of cytochrome P450 2C19 in Mexican Americans: a cross-ethnic comparative study.
    Luo HR; Poland RE; Lin KM; Wan YJ
    Clin Pharmacol Ther; 2006 Jul; 80(1):33-40. PubMed ID: 16815315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Expanding ELISA Screening in DUID Investigations to Include Carisoprodol/Meprobamate and Zolpidem.
    Lu A; Scott KS; Chan-Hosokawa A; Logan BK
    J Anal Toxicol; 2017 Mar; 41(2):134-139. PubMed ID: 27798072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations.
    Allabi AC; Gala JL; Desager JP; Heusterspreute M; Horsmans Y
    Br J Clin Pharmacol; 2003 Dec; 56(6):653-7. PubMed ID: 14616425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms of CYP2C19 and CYP2D6 in Israeli ethnic groups.
    Luo HR; Aloumanis V; Lin KM; Gurwitz D; Wan YJ
    Am J Pharmacogenomics; 2004; 4(6):395-401. PubMed ID: 15651900
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of the cytochrome P450 2C19 genetic polymorphism.
    Desta Z; Zhao X; Shin JG; Flockhart DA
    Clin Pharmacokinet; 2002; 41(12):913-58. PubMed ID: 12222994
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Mongolian population in China.
    Yang ZF; Cui HW; Hasi T; Jia SQ; Gong ML; Su XL
    Genet Mol Res; 2010 Sep; 9(3):1844-51. PubMed ID: 20845310
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.